Cilostazol With Nimodipine to Improve Outcome After Aneurysmal Subarachnoid Hemorrhage

Inclusion Criteria: * Adult patients admitted to an ICU with SAH related to a ruptured cerebral aneurysm occurring within the last 96 hours. * Aneurysm successfully secured by surgical clipping or endovascular coiling * Consent of the patient or, if not possible, from a proxy (emergency clause). * Registration in a national health care system Exclusion Criteria: * \- Precritical modified Rankin Scale (mRS) \> 2 * Nonaneurysmal SAH * Delayed \>96h admission after first symptoms of SAH * Coma defined by GCS of 3-5 with untreatable aneurysm will be excluded" * Known allergy to cilostazol * Pregnancy * Pre-existing major hepatic, renal, pulmonary or cardiac disease * Concomitant use of one other anti-platelet and/or anticoagulant agent * SAH diagnosed on Lumbar puncture with no evidence of blood on CT. * Tutelage or guardianship